Hengtong(SH:600226) Shang Hai Zheng Quan Bao·2025-08-25 21:32Core Viewpoint - The company has announced significant governance changes, including the cancellation of the supervisory board and amendments to the company’s articles of association, aimed at enhancing corporate governance and operational efficiency [58][59]. Group 1: Company Overview - The company is Zhejiang Hengtong Holding Co., Ltd., with the stock code 600226 [52]. - The company’s board of directors and supervisory board ensure the accuracy and completeness of the semi-annual report [1][53]. Group 2: Financial Data - The semi-annual report for 2025 has been approved by the board and supervisory board, confirming that it reflects the company's financial status and operational results accurately [53][54]. Group 3: Important Matters - The company plans to establish a small variety amino acid production base in Hohhot, Inner Mongolia, which will add 11,880 tons/year of production capacity, including L-Tryptophan (7,380 tons/year), L-Arginine (2,100 tons/year), and L-Isoleucine (2,400 tons/year) [4]. - The board has proposed to revise the articles of association, including the removal of the vice-chairman position and the supervisory board, transferring its powers to the audit committee [58][59]. Group 4: Governance Changes - The company has proposed multiple amendments to governance documents, including the rules for shareholder meetings, board meetings, and various management systems, all of which require approval at the upcoming shareholders' meeting [10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49].